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摘  要 
Aigialomycin D是从海生红树林菌类Aigialus parvus BCC 5311 中分离出来的
一种具有重要生理活性的间二羟苯基大环内酯天然产物。该化合物具有强的抗癌
活性（IC50：3.0 µg/mL对 KB 细胞）和抗疟疾活性（IC50：6.6 µg/mL对 P. 
falciparum）。从化学结构来看，Aigialomycin D是个间二苯酚与 14 员大环内酯相









































P:保护基TBS; R:甲基或乙基  
图一 Aigialomycin D 逆合成分析 
通过对 Aigialomycin D 进行逆合成分析（图一），可将其分为三个片段，其
中片段Ⅱ为商业试剂，故本论文的工作之一是合成片段Ⅰ和Ⅲ，所得结果如下： 
（一）由 3,5-二羟基甲苯出发，经芳香环上的甲酰化、醛基氧化、羧基甲酯
化和酚羟基 TBS 保护，经四步以 56％的总收率得到片段Ⅰ（图二）： 
HO OH TBSO OTBS
COOCH356%
Ⅰ  
图二 由 3,5-二羟基甲苯出发合成片段Ⅰ 
（二）由乙酰乙酸酯出发，经二聚得到 2,4-二羟基-6-甲基苯甲酸酯，酚羟基
用 TBSCl 保护，经两步分别以 55％（甲酯）和 52％（乙酯）的总收率得到片段


















COORR: Me 总收率 55%
R: Et   总收率52%
Ⅰ  
图三 由乙酰乙酸酯出发合成片段Ⅰ 
（三）由异维生素 C 出发，经转化得(2R ,3R)-二羟基 -γ-丁内酯，再经邻
二羟基缩丙酮保护，内酯基还原，环内半缩醛 Wittig 反应，烯烃双键催化氢化，












图四 由异维生素 C 出发合成片段Ⅲ 
（四）由 D-(-)-核糖出发，经邻二羟基缩丙酮保护，环内半缩醛 Wittig 反应，












图五 由 D-(-)-核糖出发合成片段Ⅲ 





种叫做Eupatorium Fortunei TURZ的植物中分离得到。Eupatorium Fortunei TURZ
这种植物在中国和日本的民间，用于利尿、退热、通经和抗糖尿病等治疗用途，
化合物72、73、74被证实是该植物提取液中的主要活性物质。该类生物碱均具有




































72 73 74 75  
图六 3,4,5-三羟基哌啶系列化合物 
我们以异维生素 C 为原料，经转化得(2R ,3R)-二羟基 -γ-丁内酯，再经邻
二羟基缩丙酮保护，内酯基还原，环内半缩醛 Wittig 反应，伯羟基的甲磺酸酯活
化，末端烯键的环氧化，苄胺亲核取代并成环，脱保护，经八步以 16％的总收
率合成了(3R,4S,5S)-3,4,5-三羟基哌啶 73 的盐酸盐 73·HCl，以 8％的总收率合成

















16% 8%  
图七 由异维生素 C 出发合成 3,4,5-三羟基哌啶盐酸盐 
 
关键词: 异维生素 C；D-(-)-核糖；Aigialomycin D；(2R ,3R)-二羟基 -γ-丁内
酯； 3,4,5-三羟基哌啶。 















This thesis contains two major parts, the syntheses of two key fragments I and III 
for a total synthesis of the natural product aigialomycin D and two 3, 4, 5-trihydroxy 
piperidines. 
The first part of this thesis describes the synthesis of two key fragments I and III 
for a total synthesis of aigialomycin D. 
 Aigialomycin D is a 14-membered resorcinylic macrolide isolated from the 
marine mangrove fungus Aigialus parvus BCC5311. This compound possesses potent 
antitumour (IC50: 3.0µg/ml against KB cells) and anti-malarial activity (IC50: 
6.6µg/ml against P. falciparum). Structurally, aigialomycin D has a resorcin unit fused 
with a 14-membered macrolactone with 3 chiral centres and 2 E-double bonds. Its 
interesting biological activity combined with fair degree of structural complexity 
makes aigialomycin D an interesting target for total synthetic studies. 









































P = TBS; R = Me or Et  
 
Fig. 1 Retrosynthetic analysis of aigialomycin D 
Retrosynthetically, aigialomycin D can be disconnected into three key fragments I 
















The resorcin derivative I has been synthesised via two routes. On the one hand, 
formylation of orcinol followed by oxidation to carboxylic acid, esterification and 
TBS protection of the phenolic group provides I in 4 steps in 56% overall yield.（Fig. 
2）： 
HO OH TBSO OTBS
COOCH356%
Ⅰ  
Fig. 2 Synthesis of fragment I from orcinol 
 
On the other hand, cyclodimerization of methyl or ethyl acetoacetate gives 2, 
4-dihydroxy-6-methyl-benzoate which is then TBS protected to provide I in two steps 







Fig. 3 Synthesis of fragment I from acetoacetate 
Two alternative routes have also been developed for the synthesis of the aldehyde 
fragment III. On the one hand, protection of (2R, 3R)-dihydroxy-γ-lactone prepared 
from iso-ascorbic acid, followed by reduction of the lactone to lactol, Wittig reaction 
of the lactol, hydrogenation of the resulting alkene, PCC oxidation of the primary 
alcohol to aldehyde, elongation of one carbon by Wittig methylenation and final 
controlled DIBAL-H reduction of the ester to form the aldehyde, provides the 











Fig. 4 Synthesis of fragment III from iso-ascorbic acid 















followed by Wittig reaction of the lactol, hydrogenation of the resulting alkene, 
cleavage of the diol to form the aldehyde, methylenation of the aldehyde and final 
controlled DIBAL-H reduction of the ester to form the aldehyde, provides the 











Fig. 5 Synthesis of the fragment III D-(-)-ribose 
The above achievement on the syntheses of fragments I and III has laid a solid 
foundation for a total synthesis of aigialomycin D. 
The second part of the thesis describes the synthesis of two 3, 4, 5-trihydroxy 
piperidines. 
3, 4, 5-Trihydroxy piperidines 72-75 (Fig. 6) are a small group of four 
polyhydroxy piperidine alkaloids, of which 72-74 were isolated by Kusano et al in 
1995 from Eupatorium Fortunei TURZ, a folk medicinal plant used for the treatment 
of several ailments. Compounds 72-74 have been proven to be the major effective 
components in Eupatorium Fortunei TURZ. These alkaloids show β-glucosidase 






















72 73 74 75  
Fig.6 3, 4, 5- Trihydroxy piperidines 
Using (2R, 3R)-dihydroxy-γ-lactone prepared from iso-ascorbic acid as the 
starting material, a concise and stereoselective route has been developed for the 
synthesis of trihydroxy piperidine 73 and 75 as their hydrochloride. Acetonide 
formation of (2R, 3R)-dihydroxy-γ-lactone, followed by reduction of the lactone to 















epoxidation of the terminal alkene followed by separation of the two isomeric 
epoxides, nucleophilic displacement of the mesylate and opening of the epoxide 
forming the piperidine ring, final hydrogenolysis in HCl provides trihydroxy 
piperidine 73 and 75 as their hydrochloride in 8 steps in 16% and 8% overall yields 

















16% 8%  
Fig. 7 Synthesis of trihydroxy piperidine 73 and 75 hydrochloride from 
iso-ascorbic acid 
Keywords: iso-ascorbic acid ； D-(-)-ribose ； (2R ,3R)-dihydroxy-γ-lactone; 
















































































































































第一章 天然产物 Aigialomycin D 部分片段的合成 
第一章 天然产物 Aigialomycin D 部分片段的合成 
第一节 文献回顾 
Aigialomycin A-E（图 1.1）是 2002 年由Isaka等人从海生红树林菌类Aigialus 
parvus BCC 5311 中分离出来的一系列间二羟苯基大环内酯天然产物。其中化合
物Aigialomycin D具有强的抗癌活性（IC50：3.0 µg/mL对 KB 细胞）和抗疟疾活


















































尤其是 1'，2'位有无环氧结构的差异，且环氧化发生于 1'，2'位的 E-构型双键；





含有 3 个手性中心和 2 个 E-构型双键的化合物。其有意义的生理活性和较为复
杂的结构特点使得 Aigialomycin D 成为一个具有挑战性的全合成目标物。 
到目前为止，天然产物 Aigialomycin D的全合成共有两条路线：（1）2004 年，
美国哥伦比亚大学Danishefsky课题组首次完成Aigialomycin D的全合成[2]；（2）
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